Zobrazeno 1 - 10
of 264
pro vyhledávání: '"Harlozinska, A"'
Autor:
Dorn, J. *, Magdolen, V., Gkazepis, A., Gerte, T., Harlozinska, A., Sedlaczek, P., Diamandis, E.P., Schuster, T., Harbeck, N., Kiechle, M., Schmitt, M.
Publikováno v:
In Annals of Oncology August 2011 22(8):1783-1790
Autor:
Gisterek, Iwona, Sedlaczek, Paweł, Kornafel, Jan, Harłoziñska-Szmyrka, Antonina, Łacko, Aleksandra
Publikováno v:
In American Journal of Otolaryngology--Head and Neck Medicine and Surgery 2007 28(2):73-77
Autor:
Schlade-Bartusiak, Kamila, Sasiadek, Maria M., Bar, Julia K., Urbschat, Steffi, Blin, Nikolaus, Montenarh, Mathias, Harłozińska-Szmyrka, Antonina
Publikováno v:
In Cancer Genetics and Cytogenetics 2006 164(1):10-15
Publikováno v:
In Reports of Practical Oncology & Radiotherapy 2005 10(2):17-23
Autor:
van Dalen, A., Favier, J., Burges, A., Hasholzner, U., de Bruijn, H.W.A., Dobler-Girdziunaite, D., Dombi, V.H., Fink, D., Giai, M., McGing, P., Harlozinska, A., Kainz, Ch., Markowska, J., Molina, R., Sturgeon, C., Bowman, A., Einarsson, R.
Publikováno v:
In Gynecologic Oncology December 2000 79(3):444-450
Publikováno v:
Scandinavian Journal of Haematology. 25:205-213
Acute myelogenous leukaemia cells (AML) and cells of chronic myelogenous leukaemia blast crisis (CGL-CB) were examined for the presence of receptors for Fc IgG fragment (FcR), receptors for the complement components (CR1 and CR2), and the surface imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ab0d4ef55632dcc2657686a1d5be00f
https://doi.org/10.1111/j.1600-0609.1981.tb01390.x
https://doi.org/10.1111/j.1600-0609.1981.tb01390.x
Publikováno v:
Cancer. 95:1886-1893
BACKGROUND The serum markers CA125, tissue polypeptide specific antigen (TPS), and soluble interleukin-2 receptor alpha (sIL-2Rα) concentrations were determined in sera, cyst, and ascitic fluids from patients with malignant and benign ovarian neopla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d73102292d3a575e647b09ecc669008a
https://doi.org/10.1002/cncr.10917
https://doi.org/10.1002/cncr.10917
Autor:
Marian Kochman, Andrzej Ożyhar, Jan Rodriguez Parkitna, Ewa Wyrodek, Mathias Montenarh, A. Harlozinska, Julia K. Bar, Sabine Kartarius
Publikováno v:
Japanese Journal of Cancer Research : Gann
OvBH-1 cells from a patient with ovarian clear cell carcinoma were established and their biochemical status was analyzed. Cells grown at 37 degrees C exhibited normal cell cycle distribution, whereas the cells shifted to 31 degrees C were arrested in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75eef478cc12e5462503e7fb56766b00
http://europepmc.org/articles/PMC5927136
http://europepmc.org/articles/PMC5927136
Publikováno v:
Tumor Biology. 22:83-91
p53 alterations are considered as one of the most important factors responsible for drug resistance in ovarian carcinomas, although the relationship between p53 gene status and response to cisplatin-based chemotherapy in ovarian cancer patients remai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::706c88382cb72204154a2a9f0c98eb09
https://doi.org/10.1159/000050601
https://doi.org/10.1159/000050601
Autor:
V. H. Dombi, R. Einarsson, A. Bowman, Ch. Kainz, Catharine M. Sturgeon, M. Giai, Alexander Burges, U. Hasholzner, Daniel Fink, J. Markowska, P. McGing, H. W. A. de Bruijn, J. Favier, A. Harlozinska, Rafael Molina, A. van Dalen, D. Dobler-Girdziunaite
Publikováno v:
Gynecologic Oncology, 79(3), 444-450. ACADEMIC PRESS INC ELSEVIER SCIENCE
Objective. To evaluate the prognostic significance of and predictive value for survival of CA 125 and TPS levels after three chemotherapy courses in ovarian cancer patients. Methods. We analyzed in a prospective multicenter study the 1- and 2-year ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8b209a25adc5555ad194c40896f6dda
https://doi.org/10.1006/gyno.2000.5982
https://doi.org/10.1006/gyno.2000.5982